Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
emphasysmedical.com

See what CB Insights has to offer

Founded Year

2000

Stage

Series E | Alive

Total Raised

$58.3M

Last Raised

$18.14M | 16 yrs ago

About Emphasys Medical

Emphasys Medical has developed an innovative device called the Emphasys Endobronchial Valve* (EBV). The EBV is implanted in the diseased portions of the lung and utilizes a one-way valve to prevent air from entering the diseased lung segments during inhalation yet allows trapped air to vent during exhalation. This design is intended to allow inhaled air to be redirected to the healthier, functional parts of the lung. The Emphasys procedure is a minimally invasive treatment option in which the device is placed in selectively targeted areas of the affected lung determined by the extent of the emphysema damage.

Emphasys Medical Headquarter Location

700 Chesapeake Drive

Redwood City, California, 94063,

United States

650-364-0400

Latest Emphasys Medical News

Endobronchial Valves Market Revenue to Record Stellar Growth Rate During 2018 – 2028

Jan 31, 2020

Endobronchial valves were developed  primarily by the start-up medical device company Emphasys Medical (now Pulmonx – Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient’s chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply allowing the most diseased portions of the lung to collapse. Emphasys was purchased by Pulmonx in 2009 Chronic obstructive pulmonary disease (COPD) is a widespread, progressive lung disease for which pulmonologists in the US have had few new treatment options available outside the standard pharmacological therapies, lung rehabilitation and high-risk lung volume reduction surgery. Now emerging technologies, in particular, endobronchial valves, which aim to shrink hyperinflated lungs in severe emphysema patients, could soon become the first minimally invasive treatment option available in the US. Enquiry More About This Report:  https://www.trendsmarketresearch.com/report/sample/3191 The major factor expected to drive the growth of the endobronchial valves market is growing awareness regarding procedure for bronchoscopic lung volume reduction in various lung-related diseases. The increasing prevalence of tobacco smoking worldwide is consequently expected to contribute to the growth of the endobronchial valves market. The chronic obstructive pulmonary disease (COPD) is one of the major lung disorders. With the growing geriatric population, who are more commonly susceptible to lung disease, the demand for endobronchial valve is expected to increase at a linear speed. Endobronchial Valves Market: Segmentation Request  Report For Toc:  https://www.trendsmarketresearch.com/report/requesttoc/3191 The global endobronchial valves market can be segmented on the basis of product type, end user, and geography. Based on product type, the global endobronchial valves market is segmented as: Duckbill-shaped Endobronchial Valves, Umbrella-shaped Endobronchial Valves Based on the end user, the global endobronchial valves market is segmented as: Hospitals,Clinical Research Center, Ambulatory Surgery Center, Others Regional analysis includes: North America (U.S., Canada), Latin America (Mexico, Brazil, Argentina, Chile, Peru, rest of Latin America), Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, rest of Europe), CIS & Russia, Asia Pacific Excluding Japan (Greater China, India, South Korea, ASEAN Countries, Rest of APEJ), Japan, Middle East and Africa (GCC, S. Africa, Turkey, Iran, Israel, Rest of MEA) Key players operating in the market include Pulmonx Corporation (Zephyr), SpirationInc, etc. Full View of Report Description:  https://www.trendsmarketresearch.com/report/endobronchial-valves-market

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.